(TLX) Talanx - Ratings and Ratios
Property, Casualty, Life, Reinsurance, Bancassurance
EPS (Earnings per Share)
Revenue
Dividends
| Dividend Yield | 2.37% |
| Yield on Cost 5y | 10.36% |
| Yield CAGR 5y | 16.14% |
| Payout Consistency | 99.6% |
| Payout Ratio | 29.7% |
| Risk via 5d forecast | |
|---|---|
| Volatility | 22.0% |
| Value at Risk 5%th | 33.5% |
| Relative Tail Risk | -7.37% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 1.28 |
| Alpha | 37.27 |
| CAGR/Max DD | 2.58 |
| Character TTM | |
|---|---|
| Hurst Exponent | 0.364 |
| Beta | 0.060 |
| Beta Downside | 0.198 |
| Drawdowns 3y | |
|---|---|
| Max DD | 15.96% |
| Mean DD | 4.37% |
| Median DD | 3.70% |
Description: TLX Talanx December 17, 2025
Talanx AG (XETRA:TLX) is a German-based insurer and reinsurer offering a broad portfolio that spans life, health, casualty, motor, aviation, property, cyber, and parametric solutions, as well as bancassurance and asset-management services. The group operates globally through its HDI subsidiary and serves both retail and corporate customers.
According to the 2023 annual report (the most recent public filing as of Dec 2025), Talanx generated €31.5 bn in gross written premiums, posted a combined ratio of 96.2 % (indicating underwriting profitability), and delivered a net profit of €1.1 bn, corresponding to a return on equity (ROE) of roughly 9 %. These figures assume the reported numbers are comparable year-over-year and that no material restatements have occurred since publication.
Key drivers of Talanx’s performance include: (1) the low-interest-rate environment, which compresses investment income on its sizable asset base; (2) heightened climate-related loss exposure, especially for property lines, prompting increased capital allocation to reinsurance and parametric products; and (3) accelerating digital transformation and cyber-risk demand, which are expanding premium opportunities but also requiring higher technology spend. All three factors are subject to macro-economic volatility and regulatory changes (e.g., Solvency II revisions), introducing uncertainty into future earnings.
For a deeper, data-driven view of how these dynamics translate into valuation metrics, you might explore Talanx’s profile on ValueRay.
Piotroski VR‑10 (Strict, 0-10) 5.5
| Net Income (2.35b TTM) > 0 and > 6% of Revenue (6% = 1.51b TTM) |
| FCFTA 0.05 (>2.0%) and ΔFCFTA 0.43pp (YES ≥ +1.0pp, WARN ≥ +0.5pp) |
| NWC/Revenue -1.19% (prev 7.31%; Δ -8.49pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp) |
| CFO/TA 0.07 (>3.0%) and CFO 12.01b > Net Income 2.35b (YES >=105%, WARN >=100%) |
| Net Debt (3.62b) to EBITDA (5.39b) ratio: 0.67 <= 3.0 (WARN <= 3.5) |
| Current Ratio 0.80 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active) |
| Outstanding Shares last Quarter (258.2m) change vs 12m ago 0.24% (target <= -2.0% for YES) |
| Gross Margin 20.24% (prev -1.96%; Δ 22.20pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0) |
| Asset Turnover 14.08% (prev 16.78%; Δ -2.70pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0) |
| Interest Coverage Ratio 4.60 (EBITDA TTM 5.39b / Interest Expense TTM 280.0m) >= 6 (WARN >= 3) |
Altman Z'' 0.29
| (A) -0.00 = (Total Current Assets 1.22b - Total Current Liabilities 1.52b) / Total Assets 179.50b |
| (B) 0.06 = Retained Earnings (Balance) 10.35b / Total Assets 179.50b |
| (C) 0.01 = EBIT TTM 1.29b / Avg Total Assets 179.20b |
| (D) 0.06 = Book Value of Equity 9.98b / Total Liabilities 159.90b |
| Total Rating: 0.29 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D) |
ValueRay F-Score (Strict, 0-100) 63.32
| 1. Piotroski 5.50pt |
| 2. FCF Yield -9.91% |
| 3. FCF Margin 33.42% |
| 4. Debt/Equity 0.70 |
| 5. Debt/Ebitda 0.67 |
| 6. ROIC - WACC (= 1.55)% |
| 7. RoE 19.37% |
| 8. Rev. Trend -24.30% |
| 9. EPS Trend 82.57% |
What is the price of TLX shares?
Over the past week, the price has changed by +0.62%, over one month by +2.80%, over three months by +0.53% and over the past year by +42.18%.
Is TLX a buy, sell or hold?
What are the forecasts/targets for the TLX price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 110.2 | -3.2% |
| Analysts Target Price | - | - |
| ValueRay Target Price | 160.1 | 40.7% |
TLX Fundamental Data Overview December 26, 2025
Market Cap EUR = 29.36b (29.36b EUR * 1.0 EUR.EUR)
P/E Trailing = 12.4945
P/E Forward = 11.4286
P/S = 0.6962
P/B = 2.3119
P/EG = 0.9367
Beta = 0.427
Revenue TTM = 25.23b EUR
EBIT TTM = 1.29b EUR
EBITDA TTM = 5.39b EUR
Long Term Debt = 8.37b EUR (from longTermDebt, last fiscal year)
Short Term Debt = 293.0m EUR (from shortTermDebt, last fiscal year)
Debt = 8.90b EUR (from shortLongTermDebtTotal, last fiscal year)
Net Debt = 3.62b EUR (from netDebt column, last fiscal year)
Enterprise Value = -85.08b EUR (29.36b + Debt 8.90b - CCE 123.34b)
Interest Coverage Ratio = 4.60 (Ebit TTM 1.29b / Interest Expense TTM 280.0m)
FCF Yield = -9.91% (FCF TTM 8.43b / Enterprise Value -85.08b)
FCF Margin = 33.42% (FCF TTM 8.43b / Revenue TTM 25.23b)
Net Margin = 9.31% (Net Income TTM 2.35b / Revenue TTM 25.23b)
Gross Margin = 20.24% ((Revenue TTM 25.23b - Cost of Revenue TTM 20.12b) / Revenue TTM)
Gross Margin QoQ = 2.98% (prev -656.4%)
Tobins Q-Ratio = -0.47 (set to none) (Enterprise Value -85.08b / Total Assets 179.50b)
Interest Expense / Debt = 0.04% (Interest Expense 4.00m / Debt 8.90b)
Taxrate = 20.32% (239.0m / 1.18b)
NOPAT = 1.03b (EBIT 1.29b * (1 - 20.32%))
Current Ratio = 0.80 (Total Current Assets 1.22b / Total Current Liabilities 1.52b)
Debt / Equity = 0.70 (Debt 8.90b / totalStockholderEquity, last quarter 12.70b)
Debt / EBITDA = 0.67 (Net Debt 3.62b / EBITDA 5.39b)
Debt / FCF = 0.43 (Net Debt 3.62b / FCF TTM 8.43b)
Total Stockholder Equity = 12.13b (last 4 quarters mean from totalStockholderEquity)
RoA = 1.31% (Net Income 2.35b / Total Assets 179.50b)
RoE = 19.37% (Net Income TTM 2.35b / Total Stockholder Equity 12.13b)
RoCE = 6.28% (EBIT 1.29b / Capital Employed (Equity 12.13b + L.T.Debt 8.37b))
RoIC = 6.34% (NOPAT 1.03b / Invested Capital 16.18b)
WACC = 4.80% (E(29.36b)/V(38.26b) * Re(6.24%) + D(8.90b)/V(38.26b) * Rd(0.04%) * (1-Tc(0.20)))
Discount Rate = 6.24% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 8.05%
Shares Correlation 3-Years: 0.0 | Cagr: 0.0%
[DCF Debug] Terminal Value 77.89% ; FCFE base≈8.11b ; Y1≈7.90b ; Y5≈7.95b
Fair Price DCF = 547.1 (DCF Value 141.27b / Shares Outstanding 258.2m; 5y FCF grow -3.72% → 3.0% )
EPS Correlation: 82.57 | EPS CAGR: 20.42% | SUE: -1.10 | # QB: 0
Revenue Correlation: -24.30 | Revenue CAGR: 23.47% | SUE: 0.93 | # QB: 1
EPS next Year (2026-12-31): EPS=10.41 | Chg30d=+0.209 | Revisions Net=+4 | Growth EPS=+13.6% | Growth Revenue=+4.6%